Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pacira Pharmaceuticals, Inc. (PCRX)  
$26.25 0.20 (0.77%) as of 4:30 Tue 4/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 49,450,000
Market Cap: 1.30(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $25.5 - $46.6
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  623
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 119,323 119,323 201,796 291,198
Total Sell Value $3,656,226 $3,656,226 $6,836,738 $12,122,941
Total People Sold 1 1 15 17
Total Sell Transactions 3 3 36 59
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 781
  Page 9 of 32  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Winston Roy Chief Clinical Officer   •       –      –    2021-03-31 4 OE $34.38 $472,656 D/D 13,750 48,535     -
   Stack David M CEO and Chairman   •       •      –    2021-03-24 4 GD $0.00 $0 I/I 1,080 97,273     -
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2021-03-17 4 S $70.01 $140,020 D/D (2,000) 13,181 16%     
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2021-03-17 4 OE $10.81 $21,620 D/D 2,000 15,181     -
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2021-03-15 4 S $73.28 $111,386 D/D (1,520) 13,181 19%     
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2021-03-15 4 OE $10.81 $16,431 D/D 1,520 14,701     -
   Froimson Mark Director   –       •      –    2021-03-15 4 S $72.26 $53,039 D/D (734) 5,242 19%     
   Wicki Andreas Director   –       •      –    2021-03-15 4 S $73.68 $781,082 I/I (10,601) 451,324 19%     
   Wicki Andreas Director   –       •      –    2021-03-12 4 S $73.10 $4,294,917 I/I (58,754) 461,925 21%     
   Wicki Andreas Director   –       •      –    2021-03-11 4 S $72.70 $4,403,730 I/I (60,574) 520,679 20%     
   Wicki Andreas Director   –       •      –    2021-03-10 4 S $71.78 $5,489,734 I/I (76,480) 581,253 21%     
   Wicki Andreas Director   –       •      –    2021-03-09 4 S $70.90 $2,491,213 I/I (35,137) 657,733 21%     
   Hastings Paul J Director   –       •      –    2021-03-05 4 S $65.88 $197,640 D/D (3,000) 6,116 19%     
   Hastings Paul J Director   –       •      –    2021-03-05 4 OE $13.98 $41,940 D/D 3,000 9,116     -
   Longenecker John P Phd Director   –       •      –    2021-03-01 4 S $72.26 $361,300 D/D (5,000) 17,757 22%     
   Longenecker John P Phd Director   –       •      –    2021-03-01 4 OE $13.98 $69,900 D/D 5,000 22,757     -
   Stack David M CEO and Chairman   •       •      –    2021-02-03 4 AS $70.78 $1,513,259 D/D (21,250) 76,061 -17%     
   Stack David M CEO and Chairman   •       •      –    2021-02-03 4 OE $10.81 $229,713 D/D 21,250 97,311     -
   Stack David M CEO and Chairman   •       •      –    2021-02-02 4 AS $68.41 $1,474,874 D/D (21,250) 76,061 -14%     
   Stack David M CEO and Chairman   •       •      –    2021-02-02 4 OE $10.81 $229,713 D/D 21,250 97,311     -
   Reinhardt Max President   •       –      –    2021-01-06 4 AS $60.81 $6,689 D/D (110) 14,000 -2%     
   Brege Laura Director   –       •      –    2020-11-16 4 S $65.95 $791,400 D/D (12,000) 7,921 -11%     
   Brege Laura Director   –       •      –    2020-11-16 4 OE $13.98 $167,760 D/D 12,000 19,921     -
   Reinhardt Max President   •       –      –    2020-11-13 4 AS $62.67 $1,584,390 D/D (25,000) 14,000 13%     
   Reinhardt Max President   •       –      –    2020-11-13 4 OE $42.54 $1,063,500 D/D 25,000 39,000     -

  781 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 32
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed